Week News Release: Patents Granted News in Biosynthetic Drugs From November 18 To 25

Nov 25, 2024 Leave a message

According to the news on November 23,

Zhejiang Haoqing Biotechnology Co., Ltd. obtained a patent titled "A mutant of L-threonine aldolase and its application in the synthesis of L-p-methylsulfonylphenylserine", with the authorization announcement number CN118497167B.

Liaoning Zhonghui Biotechnology Co., Ltd. was granted a patent named "A synthesis method of 1-(4-chlorophenyl)-2-cyclopropyl-1-propanone", with the authorization announcement number CN116396155B.

Shandong Guobang Pharmaceutical Co., Ltd. and Guobang Pharmaceutical Group Co., Ltd. jointly obtained a patent titled "A synthesis method of 3,4,5-trifluorobromobenzene" with the authorization announcement number CN118637975B.

According to the news on November 21, Sichuan Yingjia Hesheng Technology Co., Ltd. received a patent titled "A sucrose synthase and its application in the biosynthesis of steviol glycosides", with the authorization announcement number CN118755690B.